Interstitial lung disease in the connective tissue diseases

Area of Science:

• Rheumatology
• Pulmonology
• Immunology

Background:

• Connective tissue diseases (CTDs) are inflammatory, immune-mediated disorders.
• Interstitial lung disease (ILD) is a common and significant complication of CTDs.
• ILD can be the initial clinical presentation of an underlying CTD.

Purpose of the Study:

• To highlight the importance of recognizing interstitial lung disease (ILD) in the context of connective tissue diseases (CTDs).
• To emphasize the diagnostic considerations and therapeutic approaches for CTD-associated ILD.

Main Methods:

• Literature review on CTD-associated ILD.
• Clinical presentation analysis of CTD-ILD.
• Diagnostic criteria and treatment strategies for CTD-ILD.

Main Results:

• Interstitial lung disease (ILD) is a frequent and critical manifestation of connective tissue diseases (CTDs).
• CTD-ILD often presents insidiously with cough and dyspnea, but can rarely manifest as acute respiratory failure.
• Exclusion of infection and drug reactions is essential; idiopathic ILD diagnosis requires ruling out underlying CTD.

Conclusions:

• A thorough investigation for underlying CTD is imperative before diagnosing idiopathic ILD.
• Treatment for CTD-associated ILD typically involves corticosteroids and immunosuppressive agents.
• Recognizing ILD as a potential early sign of CTD is vital for timely and appropriate patient management.